Recommendations for patients with occupational locomotory disorders include ultrasonography, diagnostic and therapeutic arthroscopy, target therapy of systemic osteoporosis with monohydrate zoledronic acid (aclasta)--that enables prolong remission (up to 46.2 months).
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
[prospects hi-tech
4
hi-tech medicine
4
medicine development
4
development occupational
4
occupational pathology
4
pathology exemplified
4
exemplified joints
4
joints diseases
4
diseases model]
4
model] recommendations
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!